Cybin Inc. (CYBN)
USD 6.5
(-1.81%)
USD 6.5
(-1.81%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -9.50 CAD | -4218.18% |
| 2022 | -0.22 CAD | 48.84% |
| 2021 | -0.43 CAD | -34.37% |
| 2020 | -0.32 CAD | -566.67% |
| 2019 | -0.05 CAD | -566.67% |
| 2018 | -0.01 CAD | 0.0% |
| 2016 | -0.01 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.02 CAD | -2604.63% |
| 2023 Q3 | -0.09 CAD | -79.29% |
| 2023 FY | - CAD | 54.55% |
| 2023 Q4 | -0.03 CAD | 69.09% |
| 2023 Q2 | -0.05 CAD | 15.5% |
| 2023 Q1 | -0.06 CAD | 14.16% |
| 2022 Q4 | -0.07 CAD | -22.85% |
| 2022 Q3 | -0.06 CAD | -3.27% |
| 2022 Q1 | -0.07 CAD | 25.8% |
| 2022 Q2 | -0.06 CAD | 25.74% |
| 2022 FY | - CAD | 48.84% |
| 2021 Q2 | -0.11 CAD | -17.9% |
| 2021 Q3 | -0.10 CAD | 9.09% |
| 2021 Q1 | -0.09 CAD | -6.63% |
| 2021 FY | - CAD | -34.37% |
| 2021 Q4 | -0.10 CAD | 0.0% |
| 2020 FY | - CAD | -566.67% |
| 2020 Q3 | -0.10 CAD | -24900.0% |
| 2020 Q4 | -0.09 CAD | 12.5% |
| 2020 Q2 | -0.00 CAD | 98.8% |
| 2020 Q1 | -0.03 CAD | 0.0% |
| 2019 Q3 | -0.01 CAD | 0.0% |
| 2019 FY | - CAD | -566.67% |
| 2018 FY | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AIM ImmunoTech Inc. | -0.60 USD | -1483.333% |
| Armata Pharmaceuticals, Inc. | -1.91 USD | -397.382% |
| Actinium Pharmaceuticals, Inc. | -1.83 USD | -419.126% |
| Azitra, Inc. | -54.76 USD | 82.652% |
| Can-Fite BioPharma Ltd. | -1.79 USD | -430.726% |
| Chromocell Therapeutics Corporation | -1.28 USD | -642.188% |
| Calidi Biotherapeutics, Inc. | -1.73 USD | -449.133% |
| CEL-SCI Corporation | -0.73 USD | -1201.37% |
| iBio, Inc. | -6.50 USD | -46.154% |
| Lineage Cell Therapeutics, Inc. | -0.12 USD | -7816.667% |
| MAIA Biotechnology, Inc. | -1.49 USD | -537.584% |
| Matinas BioPharma Holdings, Inc. | -5.28 USD | -79.924% |
| NovaBay Pharmaceuticals, Inc. | -138.65 USD | 93.148% |
| NanoViricides, Inc. | -0.70 USD | -1257.143% |
| Oragenics, Inc. | -9.18 USD | -3.486% |
| BiomX Inc. | -5.10 USD | -86.275% |
| BiomX Inc. | -5.10 USD | -86.275% |
| Protalix BioTherapeutics, Inc. | 0.12 USD | 8016.667% |
| Palatin Technologies, Inc. | -2.02 USD | -370.297% |
| Scorpius Holdings, Inc. | -347.20 USD | 97.264% |
| Theriva Biologics, Inc. | -28.49 USD | 66.655% |